---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-082708"
form_type: "8-K/A"
ticker: "HCTI"
cik: "0001839285"
company_name: "Healthcare Triangle, Inc."
filed_at: "2025-09-02T23:59:59+00:00"
generated_at: "2026-05-17T08:57:14.632665+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# HCTI amends acquisition terms to give seller 1.388M shares after reverse split; discloses audited financials

## Summary
- Amendment replaces stock consideration with 1,388,041 restricted shares, reflecting 1-for-249 reverse split, subject to shareholder approval.
- Niyama audited FY2024: revenue $3K, net loss $37K; Ezovion: revenue $258K, net income $13K.
- Pro forma combined FY2024 revenue $11.96M, net loss $5.99M; HCTI standalone had $1.1M AR and $2.65M short-term borrowing.
- HCTI standalone total liabilities $9.78M vs total assets $7.66M; combined assets $8.24M.
- Acquired entities contribute minimal revenue/assets relative to HCTI's existing losses; deal still requires shareholder approval.

## SEC filing metadata
- accession: 0001213900-25-082708
- form_type: 8-K/A
- ticker: HCTI
- cik: 0001839285
- company_name: Healthcare Triangle, Inc.
- filed_at: 2025-09-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 9.01, 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839285/000121390025082708/0001213900-25-082708-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839285/000121390025082708/ea0255323-8ka1_health.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-082708
- JSON: https://secwatch.observer/filing/0001213900-25-082708.json
- Plain text: https://secwatch.observer/filing/0001213900-25-082708.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.